Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edith A Perez
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
157 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
- University of Pretoria
Pretoria, South Africa
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Western Regional Ccop
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Community Cancer Institute
Clovis, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Washington Hospital
Fremont, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Community Hospital of Monterey Peninsula
Monterey, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Salinas Valley Memorial
Salinas, California, United States
- Naval Medical Center -San Diego
San Diego, California, United States
- University of California San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- the Angeles Clinic and Research Institute - Santa Monica Office
Santa Monica, California, United States
- Santa Rosa Memorial Hospital
Santa Rosa, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Atlanta Regional Ccop
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2000
- Primary completion
- 25 Apr 2005
- Completion
- 27 Jan 2010
- Last update posted
- 14 Aug 2020
- Registered enrollment
- 3,436
- Registry id
- NCT00005970
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.